GRAL — GRAIL, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1699031 ·
Last close
$76.58
Market Cap
$3.42B
52W High
$81.87
52W Low
$54.52
ADV30
668,583
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 44,687,000 | -12,566,000 | -148,360,000 | -110,247,000 | 2,843,686,000 | 55,645,000 | 301,032,000 |
| Mar 2026 | 40,785,000 | -14,307,000 | -135,765,000 | -93,187,000 | 2,803,474,000 | 69,344,000 | 302,788,000 |
| Dec 2025 | 43,597,000 | -11,136,000 | -124,411,000 | -99,176,000 | 2,922,015,000 | 249,727,000 | 344,153,000 |
| Sep 2025 | 36,194,000 | -13,733,000 | -125,291,000 | -88,977,000 | 2,601,031,000 | 126,892,000 | 361,068,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-294,749,000
Investing CF
$-310,043,000
Financing CF
$423,321,000
CapEx
$-1,413,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-9.75
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,415,115,000
Inventory
$17,763,000
Receivables
$19,757,000
ST Investments
$805,964,000
EBIT TTM
$-533,827,000
Pretax Income TTM
$-529,467,000
Interest Exp TTM
—
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$165,263,008
EBITDA
$-378,488,992
Free Cash Flow
$-103,579,128
Enterprise Value
$2,650,240,256
Total Cash
$861,609,024
Total Debt
$91,309,000
Shares Out
44,666,234
Trailing EPS
$-9.33
Book Value
$56.93
ROE
-16.1%
ROA
-12.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 147,172,000 | -534,163,000 | -408,351,000 | 2,922,015,000 | 344,153,000 | — | -299,007,000 |
| Dec 2024 | 125,595,000 | -768,222,000 | -2,027,005,000 | 2,983,307,000 | 479,902,000 | — | -577,156,000 |
| Dec 2023 | 93,105,000 | -796,916,000 | -1,465,685,000 | 3,913,814,000 | 267,627,000 | — | -595,800,000 |
| Dec 2022 | 55,550,000 | -742,459,000 | -5,399,098,000 | 4,937,986,000 | 291,825,000 | — | -561,313,000 |
TTM Snapshot
Revenues TTM
$28,652,000
NetIncome TTM
$-125,688,000
OpCashFlow TTM
$0
Assets (Latest)
$2,983,307,000
Forward EPS
$-9.87
Max Pain — expiry 2026-09-18
max pain strike: $75.00 · spot: $76.58 · call oi: 1,981 · put oi: 3,177
Expected Move to 2026-09-18:
±$12.10
(15.80%) —
implied range
$64.48 –
$88.68
· ATM straddle on $75.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VCYT | VERACYTE, INC. | $3.33B | $41.47 | — |
| OPCH | Option Care Health, Inc. | $3.55B | $23.67 | — |
| NHC | NATIONAL HEALTHCARE CORP | $3.58B | $228.38 | — |
| AVAH | Aveanna Healthcare Holdings, Inc. | $2.99B | $13.70 | — |
| BKD | Brookdale Senior Living Inc. | $2.89B | $12.12 | — |
News headlines (Yahoo Finance, 1h cache)
GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting
2026-08-14 07:04 · Yahoo
GRAIL (GRAL) Q2 2026 Earnings Call Transcript
2026-08-13 13:32 · Yahoo
Is GRAIL (GRAL) Fairly Valued Following Galleri Adoption Growth And The FDA Panel Date?
2026-08-08 05:12 · Yahoo
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
2026-08-07 15:05 · Yahoo
GRAIL Q2 Earnings Call Highlights
2026-08-06 02:04 · Yahoo
GRAIL Reports Second Quarter 2026 Financial Results
2026-08-05 20:02 · Yahoo
Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
2026-08-01 17:28 · Yahoo
GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference
2026-07-30 20:01 · Yahoo
GRAIL to Announce Second Quarter 2026 Financial Results
2026-07-29 20:01 · Yahoo
Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans
2026-07-16 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.